Cannabinoid Receptors in the Horse Lateral Nucleus of the Amygdala: A Potential Target for Ameliorating Pain Perception, Stress and Anxiety in Horses
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26157613 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Cristiano Bombardi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medical Sciences (UNI EN ISO 9001:2008), University of Bologna, 40126 Bologna, Italy. Hauptthemen laut MEDLINE: Anxiety, Receptors, Cannabinoid, Pain Perception, Amygdala. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NBF Lanes, Milan, Italy, NBF Lanes.
Abstract (Originalsprache)
The amygdala is composed of several nuclei, including the lateral nucleus which is the main receiving area for the input from cortical and subcortical brain regions. It mediates fear, anxiety, stress, and pain across species. Evidence suggests that the endocannabinoid system may be a promising target for modulating these processes. Cannabinoid and cannabinoid-related receptors have been identified in the amygdala of rodents, carnivores, and humans, but not in horses. This study aimed to investigate the gene expression of cannabinoid receptors 1 (CB1R) and 2 (CB2R), transient receptor potential vanilloid 1 (TRPV1), and peroxisome proliferator-activated receptor gamma (PPARγ) within the lateral nucleus of six equine amygdalae collected post mortem from an abattoir using quantitative real-time PCR, cellular distribution, and immunofluorescence. mRNA expression of CB1R and CB2R, but not TRPV1 or PPARγ, was detected. The percentage of immunoreactivity (IR) was calculated using ImageJ software. Cannabinoid receptor 1 immunoreactivity was absent in the somata but was strongly detected in the surrounding neuropil and varicosities and CB2R-IR was observed in the varicosities; TRPV1-IR showed moderate expression in the cytoplasm of somata and processes, while PPARγ-IR was weak-to-moderate in the neuronal nuclei. These findings demonstrate endocannabinoid system components in the equine amygdala and may support future studies on Cannabis spp. molecules acting on these receptors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Medical Sciences (UNI EN ISO 9001:2008), University of Bologna, 40126 Bologna, Italy.
- Department of Translational Medicine and for Romagna, University of Ferrara, 40121 Ferrara, Italy.
- Department of Veterinary Medicine, University of Teramo, 64100 Teramo, Italy.
ORCID-Profile: Cristiano Bombardi, Giulia Salamanca, Claudio Tagliavia, Rodrigo Zamith Cunha, Augusta Zannoni, Roberto Chiocchetti
Förderung
- NBF Lanes, Milan, Italy
- NBF Lanes
Zitieren
APA
Bombardi, C., Salamanca, G., Tagliavia, C., Grandis, A., Zamith Cunha, R., Gramenzi, A., De Silva, M., Zannoni, A., & Chiocchetti, R. (2025). Cannabinoid Receptors in the Horse Lateral Nucleus of the Amygdala: A Potential Target for Ameliorating Pain Perception, Stress and Anxiety in Horses. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157613
Vancouver
Bombardi C, Salamanca G, Tagliavia C, Grandis A, Zamith Cunha R, Gramenzi A, et al. Cannabinoid Receptors in the Horse Lateral Nucleus of the Amygdala: A Potential Target for Ameliorating Pain Perception, Stress and Anxiety in Horses. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157613
BibTeX
@article{Bombardi2025,
author = {Bombardi, Cristiano and Salamanca, Giulia and Tagliavia, Claudio and Grandis, Annamaria and Zamith Cunha, Rodrigo and Gramenzi, Alessandro and De Silva, Margherita and Zannoni, Augusta and Chiocchetti, Roberto},
title = {Cannabinoid Receptors in the Horse Lateral Nucleus of the Amygdala: A Potential Target for Ameliorating Pain Perception, Stress and Anxiety in Horses},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26157613}
}
EUVIMED